Plain-English translation of NCT06688422 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether incentive spirometry—a simple device that encourages you to take deep, controlled breaths—can help protect your lungs during intensive lung cancer treatment. Researchers want to see if regular deep breathing exercises can reduce inflammation and scarring of the lungs that sometimes occurs as a side effect of chemotherapy and radiation.
Lung cancer patients undergoing chemotherapy and radiation often experience serious lung complications like pneumonitis (lung inflammation) and scarring, which can harm their quality of life and breathing. This medication has shown promise in helping patients recover after surgery, but doctors want to test whether it can prevent these complications from happening in the first place during active cancer treatment.
You likely qualify if…
You likely don't qualify if…
You will use the incentive spirometry device 10 times every hour while awake, starting as soon as you enroll and continuing throughout your chemotherapy and radiation treatment, plus three months after treatment ends. You'll also complete questionnaires about your quality of life and breathing at various points during the study. The device itself is simple to use—it measures how deeply you can breathe and provides visual feedback to encourage full lung expansion.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States